A New Wave in Neurodegeneration Treatment: How Clene’s CNS Gold Nano-Particle Program (CNM-Au8®) Aims to Target Disease Progression in ALS, MS, and PD.

A New Wave in Neurodegeneration Treatment: How Clene’s CNS—Gold Nano-Particle Program (CNM-Au8®) Aims to Target Disease Progression in ALS, MS, and PD.

Wednesday, December 10, 2025

11:00 AM – 12:00 PM ET

Jason Kolbert

Head of Research
D. Boral Capital

Robert Etherington

CEO
Clene Nanomedicine

Watch Webinar